Latest

Aug 28, 2018
Benefit verification (BV) provides a detailed understanding of out of pocket costs for the prescribed treatment. Amy Jones details how AI is aiding the BV process.
Aug 28, 2018
The Senate has approved several multi-agency budget bills for the coming fiscal year that boost funding for FDA and the NIH – and include a contentious provision that requires biopharma companies to disclose product prices in direct-to consumer advertising.
Aug 20, 2018
Pharmaceutical Executive
While digital transformation in life sciences starts with digitization for compliance, it should be seen as a key lever of competitive advantage and success, writes Jaleel Shujath.
Aug 20, 2018
In an attempt to reduce high drug prices and improve its medical insurance coverage, China has initiated a series of new moves, including the recent zero import tax on a range of anticancer drugs. Jin Zhang reports.
Aug 10, 2018
New Action Plan aims to streamline development, but rebates and reimbursement block market access.
Aug 07, 2018
Pharmaceutical Executive
New York City is emerging as a hotspot for biotech incubators, including one startup whose CEO made the leap from big pharma to forging new discoveries in medical science. Michelle Maskaly reports.
Aug 06, 2018
Pharmaceutical Executive
Over the last decade, Spain has seen a significant growth in venture-capital investment in the life sciences. We explore the driving forces.
Jul 25, 2018
Scott Gottlieb is proposing to flatten out FDA’s structure by having Center directors report directly to him, giving more authority to the agency’s six product regulatory Centers and to the Office of Regulatory Affairs.
Jul 24, 2018
If advanced technologies hold the key to at least some of the productivity issues R&D organizations need to overcome, Nicholas Lakin asks what are the best strategies and operating models for exploiting these aids to their fullest potential.
Jul 20, 2018
Rising pressure to access less expensive prescription medicines available overseas is prompting the Trump administration to explore flexible import policies, reports Jill Wechsler.
native1_300x100
lorem ipsum